The contract research organization uses technology to make clinical trial recruiting, execution and management more efficient.
“[W]e are in a time when we must take a look at how to repair or build the foundation of ophthalmology research with a more efficient, innovative and collaborative approach than ever before,” Ms. Swank said in an Aug. 2 company release. “I’m very excited about the days ahead for Vial Ophthalmology CRO.”
Ms. Swank will be working with Vial’s multidisciplinary scientific advisory board, according to the news release.
